fluorescein-di-beta-d-galactopyranoside has been researched along with verapamil in 1 studies
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
Studies (fluorescein-di-beta-d-galactopyranoside) | Trials (fluorescein-di-beta-d-galactopyranoside) | Recent Studies (post-2010) (fluorescein-di-beta-d-galactopyranoside) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
28 | 0 | 3 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arttamangkul, S; Poot, M | 1 |
1 other study(ies) available for fluorescein-di-beta-d-galactopyranoside and verapamil
Article | Year |
---|---|
Verapamil inhibition of enzymatic product efflux leads to improved detection of beta-galactosidase activity in lacZ-transfected cells.
Topics: 3T3 Cells; alpha-Galactosidase; Animals; beta-Galactosidase; Cell Line; Chloroquine; Chromatography, High Pressure Liquid; Fibroblasts; Flow Cytometry; Fluoresceins; Galactosides; Gene Expression; Lac Operon; Lysosomes; Mice; Substrate Specificity; Transfection; Verapamil | 1997 |